Gossamer Bio Inc (GOSS)

[georgie18]

GOSS...$1.11...Reversal Candle setting up here...🥳...ready for another move ...Looking for Break/Hold of $1.38 and on to $1.60 Range...imo...we shall see...

georgie18

Member Level
Re: georgie18 post# 381844

Thursday, July 11, 2024 12:30:52 PM

Post#
381873
of 382071
GOSS...$1.31....HOD...Off the .66 range bottom...🥳

[Monksdream]

GOSS under $2

[georgie18]

GOSS...$1.31....HOD...Off the .66 range bottom...🥳

[georgie18]

GOSS...$1.25...Off the .66 Range Bottom...🥳

[TechandBio]

Gossamer Nice 178% move from where I got in regret not buying more a win is a win. Rivian and ICCM accumulating..
$GOSS

[georgie18]

GOSS...$1.20...Getting hits into the close...🥳

[georgie18]

GOSS...$1.17...Trying Red to Green here...🥳

[georgie18]

GOSS...$1.15...slowly creeping up off the .50 range bottom...🥳

[georgie18]

GOSS...$1.10...Red to Green here...🥳Off the .50 range bottom...

[Monksdream]

GOSS under $2

[georgie18]

GOSS...$1.04... https://schrts.co/QnRKixhB ...🥳...Looking for the $1.09 Break and a move to $1.60 plus range...Off the .50 range bottom...

[georgie18]

GOSS...9348...Trying red to green here off THE 200MA Bounce...🥳

[georgie18]

GOSS...$1.02...on the 100/200MA Break...🥳...If this holds then we have a double top to break $1.60 range...

[georgie18]

GOSS...939...🥳in the P/M...

[glenn1919]

GOSS................................https://stockcharts.com/h-sc/ui?s=GOSS&p=W&b=5&g=0&id=p86431144783

[georgie18]

GOSS...86...Perhaps we see the Break/Hold of the 100MA at .93...🥳

[georgie18]

GOSS...755...🥳...on the upper bollie Break...Break/Hold .87 and we have a runner...imo...we shall see...

[Pennyhero]

Ready for take off! 🚀🚀🚀

[georgie18]

GOSS...71s clearing here...🥳

[georgie18]

GOSS...673...Trying for the 50MA Breakout here...🥳

[georgie18]

GOSS...66...on the Upper Bollie Break...🥳

[Termite7]

Assuming phase 3 approval, what price? Thanks!!!

[FlippinNDippin]

Took a starter here. GLTA

[Monksdream]

GOSS under $2

[glenn1919]

GOSS..........................................https://stockcharts.com/h-sc/ui?s=GOSS&p=W&b=5&g=0&id=p86431144783

[glenn1919]

GOSS..................................https://stockcharts.com/h-sc/ui?s=GOSS&p=W&b=5&g=0&id=p86431144783

[glenn1919]

GOSS......................................https://stockcharts.com/h-sc/ui?s=GOSS&p=W&b=5&g=0&id=p86431144783

[Monksdream]

GOSS under $2

[Monksdream]

GOSS new 52 week low

[Monksdream]

GOSS new 52 week low

[Monksdream]

GOSS new 52 week low

[Dutch4]

Agreed!

[hippityhop]

Institutionals shorting this unmercilessly. Three trades totalling 2.4M total shares bought at 4 pm. @ .20 cent profit a share come to $468k.

[hippityhop]

This is a 100/200 percenter in next 3 months, buy this now or weep later!!

[crudeoil24]

Raymond James Initiates Coverage On Gossamer Bio with Outperform Rating, Announces Price Target of $19
7:13 am ET April 18, 2022 (Benzinga) Print
Raymond James analyst Timur Ivannikov initiates coverage on Gossamer Bio (NASDAQ:GOSS) with a Outperform rating and announces Price Target of $19.

Latest Ratings for GOSS DateFirmActionFromTo

Nov 2021SVB LeerinkMaintainsOutperform Aug 2021SVB LeerinkMaintainsOutperform Mar 2021HC Wainwright & Co.ReiteratesBuy

[crudeoil24]

Gossamer Bio, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflammation and oncology. The Company's product candidates include Seralutinib (GB002), GB004, GB5121 and GB7208. GB002 is an inhaled, small molecule, platelet-derived growth factor receptor (PDGFR), colony-stimulating factor 1 receptor (CSF1R) and c-KIT inhibitor in development for the treatment of pulmonary arterial hypertension (PAH). GB004 is a gut-targeted, oral small molecule being developed for the treatment of inflammatory bowel disease (IBD). GB5121 is an oral, irreversible, covalent, small molecule inhibitor of Bruton’s Tyrosine Kinase (BTK), in clinical development for the treatment of primary central nervous system lymphoma (PCNSL). GB7208 is an oral, small molecule, BTK inhibitor in preclinical development for the treatment of multiple sclerosis (MS).